The Glaucoma and Retinopathy Screening Study
ConditionGlaucoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorMassachusetts Eye and Ear Infirmary
About this trial
The goal of this clinical trial is to learn if a new screening approach including an artificial intelligence algorithm that analyzes fundus photographs, measurement of eye pressure and visual field testing works to screen for glaucoma.
Participants will:
Have an image of their fundus (back of the eye) taken as part of their diabetic eye screening Have a measurement of their eye pressure If needed, have a test of their side vision using a headset
Eligibility criteria
Qualifiers
Individuals with diabetes undergoing AI-based screening for diabetic retinopathy using the LumineticsCore (Digital Diagnostics) system for clinical care at primary care centers.
Individuals who are able and willing to provide informed consent for participation in the study.
Disqualifiers
None
Trial design
Treatments tested in this trial
- AI-based glaucoma screening
- IOP measurement
- Virtual Reality Visual Field Testing
Treatment groups
2,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Massachusetts Eye and Ear Infirmary
Lead sponsor
Centers for Disease Control and Prevention
Collaborator
Source ClinicalTrials.gov